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Perilipin A coats the lipid storage droplets in adipo-
cytes and is polyphosphorylated by protein kinase A
(PKA); the fact that PKA activates lipolysis in adipo-
cytes suggests a role for perilipins in this process. To
assess whether perilipins participate directly in PKA-
mediated lipolysis, we have expressed constructs coding
for native and mutated forms of the two major splice
variants of the perilipin gene, perilipins A and B, in
Chinese hamster ovary fibroblasts. Perilipins localize to
lipid droplet surfaces and displace the adipose differen-
tiation-related protein that normally coats the droplets
in these cells. Perilipin A inhibits triacylglycerol hydrol-
ysis by 87% when PKA is quiescent, but activation of
PKA and phosphorylation of perilipin A engenders a
7-fold lipolytic activation. Mutation of PKA sites within
the N-terminal region of perilipin abrogates the PKA-
mediated lipolytic response. In contrast, perilipin B ex-
erts only minimal protection against lipolysis and is
unresponsive to PKA activation. Since Chinese hamster
ovary cells contain no PKA-activated lipase, we con-
clude that the expression of perilipin A alone is suffi-
cient to confer PKA-mediated lipolysis in these cells.
Moreover, the data indicate that the unique C-terminal
portion of perilipin A is responsible for its protection
against lipolysis and that phosphorylation at the N-ter-
minal PKA sites attenuates this protective effect.
Acute mobilization of adipose triacylglyerol stores for energy
is regulated primarily by the activation state of cAMP-depend-
ent protein kinase (PKA)1 (1). Historically, this stimulation has
been attributed to phosphorylation and activation of hormone-
sensitive lipase (HSL), but as noted previously (2, 3), the mea-
ger doubling of HSL activity upon phosphorylation in vitro falls
far short of explaining the 30–100-fold activation of cellular
lipolysis upon elevation of PKA activity in isolated primary
adipocytes. Although some the of differences between the mag-
nitude of the in vitro and in vivo responses may be attributed to
the PKA-induced translocation of HSL from the cytosol to the
lipid storage droplets within adipocytes (4), it is likely that
additional factors, notably the perilipins, contribute to the cel-
lular response.
The perilipins are a class of proteins found exclusively at the
limiting surface of lipid storage droplets, i.e. at the lipid/aque-
ous interface, in adipocytes and in steroidogenic cells (5–7).
These proteins are the most abundant PKA substrates in adi-
pocytes (5), and both their subcellular location and polyphos-
phorylation by PKA suggest a role for the perilipins in PKA-
mediated lipolysis. In adipocytes, alternative mRNA splicing
gives rise to perilipins A and B, the former at much higher
levels than the latter (8). Thus far, functional studies point to
a role for the perilipins in protecting stored TAG from hydrol-
ysis by cellular lipases. Ectopic expression of perilipin A in
3T3-L1 adipoblasts results in perilipin A-coated lipid droplets
and increases the half-life of stored TAG deposits by a factor of
4.5 (9). Also, treatment of 3T3-L1 adipocytes with tumor necro-
sis factor- both reduces expression of perilipin A and increases
basal lipolysis. With the use of an adenovirus vector to main-
tain perilipin expression during tumor necrosis factor- treat-
ment, Souza et al. (10) found that expression of either perilipin
A or B was sufficient to maintain a coating of perilipin on the
droplets and to suppress tumor necrosis factor--activated li-
polysis. Such findings further support the conclusion that per-
ilipins can protect the intracellular TAG from hydrolysis by
lipases. Finally, two reports describing the phenotype of the
perilipin null (11, 12) mouse show that these animals have
greatly reduced adipose stores and constitutively high levels of
basal lipolysis in their isolated adipose cells, again consistent
with the loss of the protective effect of perilipin. In one of these
reports (12), it was shown that in the absence of perilipin, the
adipose cells droplets were coated with adipose differentiation-
related protein (ADRP), indicating that this related protein did
not substitute for perilipin in providing a protective barrier
against lipolysis in the absence of PKA activation.
None of the above studies address a role for phosphorylation
of perilipin in the lipolytic response. To this end, using CHO
cells, we have examined the functional consequences of intro-
ducing perilipin A, perilipin B, and mutant variants of these
species. We report herein that the expression of perilipin A
alone is sufficient to inhibit lipolysis by 87% and that upon
activation of PKA, lipolysis is stimulated by 7-fold. These re-
sults re-create the strong regulatory role for perilipin seen in
adipocytes and contrast with results from another system that
detected only a modest, 50% stimulation by PKA upon intro-
duction of perilipin A into cells (13). We further show that such
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regulation is abrogated upon mutation of the PKA sites that lie
within the N-terminal region of perilipin, as did Souza et al.
(13). In contrast, we report that neither native nor mutated
perilipin B provide protection.
EXPERIMENTAL PROCEDURES
Expression of Perilipins in CHO Cells—Perilipin functional studies
were conducted with CHO K-1 cells (American Type Culture Collection,
Manassas, VA) into which we introduced murine perilipins A and B and
mutated forms of these proteins in which serine residues within con-
sensus PKA sites were mutated to alanines. Mutations were made in
sets of three, by grouping the three N-terminal PKA sites (amino acids
81, 222, and 276). The accession number for murine perilipin A cDNA is
GenBankTM AY161165. The terminologies for the various constructs
are shown in Fig 1. Each mutation was made by PCR using primers
containing the mutation of interest and external primers to amplify a
small cassette, which was then cloned in-frame in mouse perilipin A
cDNA (14). The accuracy of each mutation was confirmed by sequenc-
ing. Both unmodified and mutant full-length cDNAs were cloned in the
retroviral expression vector, pSR MSV-Tk Neo. Retrovirus was pro-
duced by co-transfecting retroviral expression vectors and the packag-
ing vector, pSV  E-MLV (15), into HEK-293 T fibroblasts using calcium
phosphate. Cells were transfected for 9 h in the presence of chloram-
phenicol, following which the medium was changed to fresh Dulbecco’s
modified Eagle’s medium, and viral production was continued for 48 h.
Prior to infection, CHO-K1 fibroblasts were treated overnight with
tunicamycin (16, 17) to increase the infection rate. Cells were infected
for 24 h using medium containing 4 g/ml polybrene harvested from the
293 T cells. Immediately following infection, CHO cells were placed
under selection in 600 g/ml G418.
Lipid Loading and Hydrolysis—Cells infected with retrovirus-con-
taining perilipin inserts or control cells, which stably incorporated the
retrovirus vector lacking perilipin cDNA, were plated at a density of
0.5  106 cells/35-mm (diameter) well. After cells became adherent, the
medium was changed to F-12 (Invitrogen) supplemented with 400 M
oleic acid complexed to 0.4% bovine serum albumin to promote triacyl-
glycerol deposition. [3H]Oleic acid, at 1 106 dpm/well, was included as
a tracer. Following a 24-h loading period, the cells were washed with 4%
bovine serum albumin in PBS to remove unincorporated oleic acid.
These conditions were employed for all experiments in the present
studies, and the amount of protein per well did not differ among cells
bearing the different perilipin species; thus, data are expressed on a
per well basis. For lipid analysis, the cells were extracted with chlo-
roform:methanol (2:1) (18), and lipids were identified by thin layer
chromatography on silica gel plates (Analtech, Newark, DE). Mobile
phase 1 was acetone developed for 4 cm; mobile phase 2 was 80:20:1
petroleum ether:diethyl ether:acetic acid developed to the top of the
plate (19). To measure hydrolysis of cellular lipids, cells were loaded
with radiolabeled oleic acid as described above and placed in an efflux
medium, which was F-12 medium including 1% defatted bovine se-
rum albumin (ICN Biomedical, Aurora, OH) as a fatty acid acceptor.
The efflux of radioactivity to the medium was measured over time by
scintillation counting. TLC confirmed that all radioactivity released
to the medium was free [3H]oleic acid. Re-esterification of fatty acids
was prevented by the inclusion of 2.5 M Triacsin C (Biomol, Plym-
outh Meeting, PA), an inhibitor of acyl co-enzyme A synthetase, to the
medium. In preliminary experiments, this level of Triacsin C was
found to effectively block all fatty acid esterification in CHO cells. To
FIG. 2. Shift in perilipin A migration under SDS-PAGE follow-
ing stimulation with IBMX and forskolin. Cells expressing perili-
pin A and vector control (VC) cells were either unstimulated (lane 1)
or stimulated (lane 1) with 1 mM IBMX and 10 M forskolin for 10
min. Homogenates were subjected to SDS-PAGE and immunoblotted
with anti-perilipin and anti-ADRP antisera. The characteristic upward
shift of PKA-phosphorylated perilipin (PA) in stimulated cells
is evident.
FIG. 3. Immunofluorescence of different cell types with anti-
perilipin and anti-ADRP. Cells were infected with retroviral con-
structs bearing the indicated forms of perilipin. Abbreviations are de-
scribed in the legend for Fig. 1 except for BF, which indicates bright
field. Control indicates the empty vector with no perilipin insert. Cells
were plated, grown, and loaded with lipid, fixed, and immunostained for
perilipin and ADRP as described under “Experimental Procedures.”
FIG. 1. The various constructs pro-
duced for this study are depicted.
Peri A, full-length perilipin A; 3XN Peri A,
perilipin A with serines in three N-termi-
nal PKA sites at amino acids 81, 222, and
276 mutated to alanines; Peri B, full-
length Peri B; 3XN Peri B, perilipin B
with Ser-to-Ala mutations at residues
within PKA sites at amino acids 81, 222,
and 276.
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stimulate protein kinase A activity, cAMP levels in cells were ele-
vated by the addition of 1 mM isobutylmethylxanthine (IBMX) and 10
M forskolin. The efficacy of this stimulation method was confirmed
by immunoblotting, which revealed that upon stimulation of cells
that were expressing perilipin A, the protein migrated more slowly
under SDS-PAGE, characteristic of PKA-phosphorylated perilipin A
(Fig. 2).
RESULTS
As we reported previously (20), lipid droplets in CHO cells
are coated with ADRP (Figs. 2 and 3); this protein and the
perilipins share significant sequence homology over their N-
terminal domains (7). Upon expression of constructs that en-
code either native or mutated perilipin A, as well as native or
mutated perilipin B, the droplets acquired a coating of perilipin
and the ADRP diminished, as evidenced both by immuno-
staining (Fig. 3) and immunoblotting (Figs. 2 and 4). This
change in the lipid droplet coat protein is a reprise of the
perilipin-for-ADRP switch that occurs during differentiation of
3T3-L1 adipocytes (20). Moreover, the amounts of unmodified
and mutated perilipins A and B were highly similar. The only
cell lines carried forth to the metabolic studies below were
those in which the perilipin (A or B) expression was sufficient
to eliminate all ADRP expression, as judged both by immuno-
fluorescence and by immunoblotting. Upon repeated passage of
some perilipin A-expressing cell lines, the perilipin expression
waned, and the metabolic phenotype reverted to that similar to
the control cells with ADRP-coated droplets. In general, a re-
versal of the perilipin A phenotype occurred when the perilipin
expression declined by 50%.
To assess lipolytic activity, CHO cells were loaded with
[3H]oleic acids as described previously (9), after which the
efflux of [3H]oleic acid to the medium was monitored for 3 h.
Triacsin C was included in all incubations during the efflux
phase to prevent reutilization of fatty acids released from hy-
drolyzed TAG (21–23). In control cells (with ADRP-coated drop-
lets), nearly 30% of the stored [3H]oleic acid was released to the
medium over 3 h, and PKA activation inhibited fatty acid efflux
by about 30%. In contrast, in cells expressing perilipin A, in the
absence of PKA activation, the release of [3H]oleic acid was
suppressed by 87% when compared with that in control cells
with ADRP-coated lipid droplets. Upon activation of PKA with
the combination of forskolin and IBMX, lipolysis was activated
by 7-fold (range of 3–13-fold) over the unstimulated cells. Iin
Fig. 5 (Perilipin A panel), note that the stimulatory effects of
PKA activation on oleic acid release in Peri A cells occurred
only after a lag of 30 min. During this 30-min period, there
were no differences in the rates of oleic acid release in unstimu-
lated and stimulated cells; thereafter, lipolysis under the two
conditions diverged and remained nearly linear over the next
2.5 h. There was another highly reproducible break in the curve
at 120 min, indicating that the perilipin-mediated increase in
lipolysis is a slowly evolving process. The lipolytic rates for all
FIG. 4. Immunoblot analysis of different types of cells. Cells
from Fig. 3 were homogenized, subjected to SDS-PAGE, and stained for
perilipin and ADRP. Abbreviations are as described in legend for Fig 1.
VC, vector control; PA, perilipin A; PB, perilipin B.
FIG. 5. Time courses of [3H]oleic acid release under unstimu-
lated and stimulated conditions. Cells bearing the indicated con-
structs were loaded with [3H]oleic acid as described under “Experimen-
tal Procedures,” and the efflux of [3H]oleic acid to the medium was
tracked over 3 h. Unstimulated cells received no further treatment,
whereas stimulated cells were treated with 1 mM IBMX and 10
M isoproterenol.
TABLE I
Lipolysis in CHO cells transfected the indicated perilipin constructs
Cells were loaded with radiolabeled oleic acid as described under “Experimental Procedures” and subsequently, the rates of oleic acid release
were measured from 30 min until 3 h in unstimulated cells and in cells stimulated with the combination of IBMX and forskolin. The values shown
for lipolytic rates are the averages of individual rates calculated for 3–6 experiments (3–6 dishes per experiment). Linearity of rates was assessed
by linear regression analysis, and r-squared vales were calculated using Cricket Graph III. Significance among different groups was determined
by using a paired Student’s t test (Microsoft Excel) (27).
Lipid droplets
coated with Unstimulated r
2 Stimulated r2
nmol oleic a./h nmol oleic a./h
Control/ADRPa 7.85 .998 4.85 .996
Peri Ab 1.08 .847 8.04 .993
Peri A 3XNc 1.13 .976 1.95 .994
Peri Bd 4.39 .998 5.92 .999
Peri B 3Xe 2.52 .989 2.33 .990
a For differences between unstimulated and stimulated results, P value is 0.0003.
b For differences between unstimulated and stimulated results, P value is 0.01.
c For differences between unstimulated and stimulated results, P value is 0.03.
d For differences between unstimulated and stimulated results, P value is 0.07 (NS); NS  not significant.
e For differences between unstimulated and stimulated results, P value is 0.35 (NS); NS  not significant.
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constructs tested over the 2.5-h period are depicted in Table I.
The 30-min lag was evident in all cells infected with perilipin
species that were responsive to PKA activation. The paradox-
ical inhibition of oleic acid release upon PKA activation of
control cells occurred without a detectable lag, as shown in Fig.
4 (Vector Control Panel). Perilipin A from mouse contains six
consensus PKA phosphorylation sites (Fig. 1). We also tested a
mutant variant of perilipin A in which the three most N-
terminal serines within PKA sites were mutated to alanines
(Peri 3XN). Introduction of this form of perilipin A also pre-
vented the release of radiolabeled fatty acid stores in the ab-
sence of PKA activation, but unlike native perilipin A, the
mutant form was relatively unresponsive to PKA activation. In
contrast to the 7-fold increase with the perilipin A cells, the
activation of the mutated perilipin was merely 1.7-fold (Table
I). In contrast, perilipin B, the shorter splice variant of the
perilipin gene failed to shield the TAG from hydrolysis and the
native perilipin B, inhibiting activity by only 13%, when com-
pared with the 90% inhibition by perilipin A. Also, perilipin B
cells were unresponsive to PKA activation. Oddly, the mutated
form of perilipin B (Peri B 3X) was more protective than native
perilipin B, inhibiting lipolysis by 63% but unresponsive to
PKA activation (Table I).
Under the loading conditions used in these studies, the great
majority of the fatty acids taken up by the cells (75%) were
stored as TAG, and the distribution of tritiated oleic acid
among the phospholipid, diacylglycerol, cholesteryl ester, and
fatty acid pools was independent of the nature of coating on the
lipid droplets (Fig. 6). However, the magnitude of uptake and
storage of [3H]oleic acid in the TAG pool was dependent on
which protein coated the droplets. Cells expressing perilipin A
accumulated the greatest amount, 148.9 19.4 nmol oleic acid,
greater than the perilipin B-expressing cells, 125.6  3 nmol
oleic acid, which, in turn, was greater than control cells with
ADRP-coated droplets, 103.0  10.3 nmol oleic acid (mean 
S.E., n  6). These accumulations represent the steady state
balance between lipogenesis and lipolysis during the lipid load-
ing phase; accordingly, these levels reflect the differences in
unstimulated lipolysis since the cells were loaded under the
non-stimulated condition, i.e. no IBMX or forskolin. After the
3-h efflux incubation, the non-TAG pools lost no measurable
[3H]oleic acid (Fig. 6), whereas the TAG pools exhibited sub-
stantial losses, which again was dependent on the lipid droplet
coat protein and the PKA activation state (Fig. 7). Moreover,
TLC analysis revealed that all of the radiolabel that appeared
in the medium was in the form of [3H]oleic acid, which could be
accounted for entirely by the loss of radiolabeled fatty acid from
the intracellular TAG pool.
The percentages of TAG hydrolyzed over 3 h in control, Peri
A, and Peri A 3XN cells are summarized in Fig. 7. It is clear
that the TAG pool, presumably within the Peri A-coated pool, is
the source of the accelerated oleic acid release under
PKA-stimulation.
DISCUSSION
In the present study, we have demonstrated that expression
of perilipin in CHO fibroblasts results in perilipin-coated lipid
droplets from which the ADRP has disappeared. Perilipin A,
but not perilipin B, suppresses lipolysis of droplet TAG, and
PKA phosphorylation of perilipin A engenders a robust lipolytic
reaction despite the absence of HSL or any other PKA-medi-
FIG. 7. Percentages of TAG hydrolyzed over 3 h from control,
Peri A, and 3 XN Peri A cells. Cells were loaded with oleic acid as
described under “Experimental Procedures.” Radiolabeled TAG was
measured immediately after loading and after a subsequent 3-h incu-
bation with and without stimulation with IBMX and forskolin. Bars
represent percentages of TAG hydrolyzed over 3 h for each condition;
error bars represent mean values  S.E. (n  6).
FIG. 6. Distribution of [3H]oleic acid among lipid pools in
loaded CHO cells. Bars labeled PL (phospholipid), DG (diacylglyc-
erol), FFA (free fatty acid), TAG, and CE (cholesteryl ester) were ana-
lyzed immediately following the loading phase. Unstim TAG and Stim
TAG represent analysis of triacylglycerol following 3 h of incubation
under unstimulated and stimulated conditions, respectively.
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ated lipase. Unlike PKA-mediated lipolysis in adipocytes, the
perilipin A-mediated lipolysis occurs only after a lag of 30
min. Lipolysis is not stimulated when the serine residues
within the three PKA sites at the N-terminal region of perilipin
A are mutated to alanines.
The finding that the proteinaceous coating of the lipid drop-
lets may confer PKA-mediated regulation of TAG hydrolysis
prompts a reconsideration of the conventional view of PKA-
mediated lipolysis in adipocytes. Heretofore, such activation
was attributed primarily to the phosphorylation of HSL, fol-
lowing which the lipase was activated, but only minimally, and
translocated from the cytosol to the lipid droplet surface.
Clearly, given the above findings, one must account for the
contribution of PKA phosphorylation of perilipin to the regula-
tion of lipolysis. Interestingly, the HSL null mouse retains a
modicum of isoproterenol-stimulated lipolytic activity, which
led to the suggestion that adipocytes may contain a second
hormone-sensitive lipase (24). Given the present results, plus
the likelihood that the HSL null mouse expresses perilipins in
its adipocytes, the presence of these lipid droplet-coating pro-
teins may explain the residual PKA-activated lipolysis in the
HSL null mouse (25).
Despite the earlier report suggesting that HSL may be ex-
pressed in CHO cells (26), we detected no HSL by immunoblot-
ting the these cells nor could we detect any PKA-stimulated
lipolytic activity in CHO cell homogenates (data not shown).
Thus, the neutral lipid lipase responsible for the TAG hydrol-
ysis in the CHO cells appears unresponsive to PKA, and it is
concluded that PKA regulation of lipolysis in CHO cells ex-
pressing perilipin A results solely from the PKA phosphoryla-
tion of the perilipin. Clearly, the ability of the endogenous CHO
cell lipase(s) to hydrolyze stored TAG under the PKA-stimu-
lated condition is dependent on the phosphorylation of perilipin
A. This conclusion is supported by the finding that mutation of
selected PKA sites eliminated the regulated response. In a
separate study, we show that perilipin A acts cooperatively
with HSL in lipolysis when both proteins are introduced into
CHO cells.2 Thus, the ability of perilipin to regulate lipolysis of
the TAG within lipid droplets appears to be manifested with
any lipase that has access to the lipid droplet surface. The
enhancement of lipolytic activity by perilipin A and the endog-
enous lipase of CHO cells is clearly a time-dependent process
that requires at least 30 min after stimulation to become man-
ifest. In contrast, when both HSL and perilipin are introduced
into CHO cells, the lipolytic activation is nearly immediate
with no detectable lag.2 We assume that the phosphorylation of
HSL fosters this immediate reaction in contrast to the endog-
enous lipase, which is apparently not a PKA substrate. Oddly,
perilipin B neither protected against lipolysis nor conferred
significant PKA regulation of lipolysis, which was not antici-
pated given the results of Souza et al. (10). However, in the
present study, we expressed perilipin B without perilipin A,
whereas in the studies of Souza et al. (10), perilipin B was
introduced into cells that contained abundant perilipin A.
The fatty acids that appeared in the CHO cell medium in the
present study derived from the triolein stored in the intracel-
lular neutral lipid droplets, which were coated with either
ADRP or the perilipins introduced into the cells. No other lipid
pool contributed to the fatty acid that was released. Moreover,
stimulation of cells expressing perilipin A led to a loss solely
from the triolein from within the perilipin-coated droplets.
Thus, one may assume that the PKA-mediated increase in fatty
acid release stems from changes in the lipid droplet surface
upon phosphorylation of perilipin A, a conclusion supported by
the finding that the 3XN mutant species failed to respond to
PKA activation.
The present data permit speculation on the structural deter-
minants for perilipin function at the lipid droplet surface. If
perilipins A and B assume similar extended conformations at
the droplet surface, the greater protection against hydrolysis of
the longer splice variant, perilipin A, may be attributed to its
greater length and thus greater coverage of droplet surface, i.e.
it is the extended C-terminal tail (12 kDa) of perilipin A that
is important in protecting against lipolysis in the unstimulated
state. It follows that phosphorylation of PKA sites in the N-
terminal region induces a conformational change in the C-
terminal region that exposes portions of the lipid droplet sur-
face to lipase action under conditions of PKA activation.
In addition to the present studies on CHO cells, it is reason-
able to assume that phosphorylation of perilipin contributes to
the lipolytic activation in adipocytes. This conclusion is rein-
forced by the finding that lipolytic stimulation by -adrenergic
agonists of adipocytes from perilipin null mice is strongly
blunted despite the presence of normal amounts of HSL (12).
After completion of the present studies, a similar study ap-
peared that largely agrees with a number of the findings re-
ported herein (13), but that study did not include studies with
perilipin B, and mutational analysis was limited to the con-
struct we term Peri A 3XN (13). Although the present studies
and those of Souza et al. (13) agree qualitatively, there are
large quantitative differences between the two studies. For
example, we find that introduction of perilipin A suppresses
lipolysis by 90% when compared with control cells, whereas
Souza et al. (13) observed a suppression of about 50%. Also, we
find that activation of Peri A cells leads to 162% greater lipol-
ysis than in control cells, as compared with a 50% increment in
the other study. Further, PKA activation of perilipin A cells
produced a 700% increase in lipolysis, as compared with a
160% increase in the published study. Our findings suggest
that PKA phosphorylation of perilipin A does far more than
merely abrogate the protective effect of the perilipin, as sug-
gested by Souza et al. (13), but additionally, exposes consider-
ably more TAG to lipase activity than is exposed in the control
cells containing droplets coated with ADRP. Reasons for these
differences may include the use by Souza et al. (13) of NIH 3T3
fibroblasts engineered to be more lipogenic by using cells that
also expressed an ectopic fatty acid transporter and an ectopic
acyl synthase, whereas in the present studies, we used an acyl
synthase inhibitor to block re-esterification of fatty acids. Also,
we used CHO cells that were stably transfected with the vari-
ous perilipin constructs, whereas Souza et al. (13) infected the
cells with perilipin adenovirus. In separate studies, we, too,
used adenovirus to introduce perilipin into cells and find mod-
est effects with CHO cells similar to those reported by Souza et
al. (13) for NIH 3T3 cells.2
In parallel studies, we demonstrate both that HSL translo-
cation to lipid droplets requires that such droplets be coated
with PKA-phosphorylatable perilipin A2 and that HSL be
phosphorylated at one of its C-terminal PKA sites, Ser-659
or 660.3 Thus, the physiological activation lipolysis in adipo-
cytes is a concerted reaction between phospho-HSL and
phospho-perilipin.
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